Cann Group Ltd
CVJ
Company Profile
Business description
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Contact
Sector
Healthcare
Stock type
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
Stocks News & Analysis
video
Do you qualify as 'rich'?
Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich.
stocks
Megatrend Investing: ASX players to capitalise on the clean energy transition
Find out how you can benefit from global megatrends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,683.40 | 55.00 | 0.64% |
| CAC 40 | 7,891.68 | 14.72 | -0.19% |
| DAX 40 | 21,585.93 | 80.23 | 0.37% |
| Dow JONES (US) | 44,680.08 | 258.17 | 0.58% |
| FTSE 100 | 8,623.29 | 52.52 | 0.61% |
| HKSE | 20,597.09 | 192.87 | -0.93% |
| NASDAQ | 19,647.13 | 6.89 | -0.04% |
| Nikkei 225 | 38,831.48 | 33.11 | 0.09% |
| NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
| S&P 500 | 6,045.34 | 7.46 | 0.12% |
| S&P/ASX 200 | 8,416.90 | 37.50 | 0.45% |
| SSE Composite Index | 3,229.49 | 21.11 | -0.65% |